Sepsis and precision medicine: The leading position of Greece. The pandemic caused by the new coronavirus SARS-CoV-2 (Covid-19 disease) was the springboard for the emergence of the Greek Sepsis Study Group as a protagonist of international therapeutic developments in the treatment of patients with serious infections. On 16 December 2021, the European Medicines Agency authorized
National Conference of Hellenic Sepsis Study Group The pandemic caused by the new coronavirus SARS-CoV-2 (disease COVID-19) was the springboard for the emergence of the Greek Sepsis Study Group as a protagonist of international therapeutic developments in the treatment of patients with serious infections. After the authorization of the drug anakinra for the treatment of
ImmunoSep: Read more Download the Program 🡇 Abstract book 🡇 Available speakers' presentations (published with their granted permission): Jeremie Poschmann, Nantes University, France Despoina Koulenti, University of Athens, Greece Antoni Torres, University of Barcelona, Spain Antigone Kotsaki, Hellenic Institute for the Study of Sepsis, Greece Frank
Precision Management of Severe Infections and Sepsis: from Translational Research to Clinical Practice Download the Programme ⤵ PROGRAM DETAILS: Hours : 20 hours and 45 minutes REGISTRATION FEE FOR PARTICIPATION: € 140,00 + Vat 24% - Total € 173,60 Includes: Access to 2 days sessions, coffee breaks, congress material.
Download the Programme ⤵
From rapid diagnostics to therapeutics: a modern scientific journey The Hellenic Society of Chemotherapy is organizing a pan-Hellenic conference entitled "From rapid diagnostics to therapeutics: a modern scientific journey" on Friday, September 26, 2025, Saturday, September 27, 2025 and Sunday, September 28, 2025 with a physical presence at the Elite City Resort Hotel in Kalamata.
